804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors

• Ryan Sullivan,
• Leyre Zubiri,
• Kerry Reynolds,
• Vartan Pahalyants,
• Nicholas Theodosakis,
• Yevgeniy Semenov,
• Bruce Tiu,
• James Iheke,
• Pearl Ugwu-Dike,
• Jayhyun Seo,
• Kimberly Tang,
• Meghan Mooradian

Affiliations

Ryan Sullivan

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Leyre Zubiri

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Kerry Reynolds

3Massachusetts General Hospital, Boston, MA, USA

Vartan Pahalyants

Harvard Medical School, Boston, Massachusetts, USA

Nicholas Theodosakis

2Massachusetts General Hospital, Boston, MA, USA

Yevgeniy Semenov

2Massachusetts General Hospital, Boston, MA, USA

Bruce Tiu

1Harvard Medical School, Boston, MA, United States

James Iheke

3University of Alabama at Birmingham SoM, Birmingham, AL, United States

Pearl Ugwu-Dike

2Massachusetts General Hospital, Boston, MA, United States

Jayhyun Seo

2Massachusetts General Hospital, Boston, MA, United States

Kimberly Tang

2Massachusetts General Hospital, Boston, MA, United States

Meghan Mooradian

2Massachusetts General Hospital, Boston, MA, United States